Nuvation Bio Balance Sheet Health

Financial Health criteria checks 5/6

Nuvation Bio has a total shareholder equity of $502.7M and total debt of $8.4M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are $571.6M and $68.9M respectively.

Key information

1.7%

Debt to equity ratio

US$8.43m

Debt

Interest coverage ration/a
CashUS$549.14m
EquityUS$502.71m
Total liabilitiesUS$68.87m
Total assetsUS$571.58m

Recent financial health updates

Recent updates

Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?

Nov 20
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?

Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market

Oct 21

Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024

Aug 08

Is Nuvation Bio (NYSE:NUVB) A Risky Investment?

Aug 07
Is Nuvation Bio (NYSE:NUVB) A Risky Investment?

Nuvation Bio: A Potentially Transformative Acquisition

Jun 20

Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate

Mar 31

Nuvation: Cash Is King, Science Is An Afterthought

Oct 03

We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Sep 14
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit

Feb 14

We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely

Feb 10
We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely

We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Nov 09
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Nuvation Bio GAAP EPS of -$0.12 beats by $0.02

Nov 03

Financial Position Analysis

Short Term Liabilities: NUVB's short term assets ($565.0M) exceed its short term liabilities ($59.0M).

Long Term Liabilities: NUVB's short term assets ($565.0M) exceed its long term liabilities ($9.8M).


Debt to Equity History and Analysis

Debt Level: NUVB has more cash than its total debt.

Reducing Debt: NUVB's debt to equity ratio has increased from 0.2% to 1.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NUVB has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: NUVB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 23.8% each year


Discover healthy companies